trihexyphenidyl has been researched along with Sleep Initiation and Maintenance Disorders in 2 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DELAY, J | 1 |
| DENIKER, P | 1 |
| Singh, MM | 1 |
| Smith, JM | 1 |
1 trial available for trihexyphenidyl and Sleep Initiation and Maintenance Disorders
| Article | Year |
|---|---|
Sleeplessness in acute and chronic schizophrenia--response to haloperidol and anti-parkinsonism agents.
Topics: Acute Disease; Adult; Antiparkinson Agents; Arousal; Benztropine; Chronic Disease; Clinical Trials a | 1973 |
1 other study available for trihexyphenidyl and Sleep Initiation and Maintenance Disorders
| Article | Year |
|---|---|
[THE SECONDARY EFFECTS OF NEUROLEPTICS].
Topics: Antipsychotic Agents; Chlorpromazine; Fluphenazine; Humans; Hypotension; Imipramine; Methotrimeprazi | 1964 |